Feline probiotic lactobacilli composition and methods
View Patent ↗According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed feline gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
1. A composition comprising a biologically purified strain of adherent lactic acid bacteria of the genus Lactobacilli isolated from resected and washed feline gastrointestinal tract having probiotic activity, and having the ability to survive and colonize the gastrointestinal tract of a companion animal, wherein said strain is selected from the group consisting of Lactobacillus salivarius ss salicinius NCIMB 41287 (AHF 122A), Lactobacillus animalis NCIMB 41288 (AHF 223C), and Lactobacillus reuteri NCIMB 41289 (AHF 5119) and a carrier.
2. The composition according to claim 1 , said strain having at least 33% growth when cultured in the presence of 0.5% feline bile salts.
3. The composition according to claim 1 , wherein the strain of adherent lactic acid bacteria is able to maintain viability following 1 hour at pH 2.5.
4. The composition according to claim 1 , wherein the lactic acid bacterial strain has a 16s-23s spacer region DNA sequence selected from SEQ. ID NO. 1, SEQ. ID NO. 2, or SEQ. ID NO. 3.
5. The composition according to claim 1 , wherein the companion animal is a cat.
6. The composition according to claim 1 , wherein said composition is in a form selected from the group consisting of a companion animal food, kibbles, chews, a supplement, a gravy, yoghurt, cheese, dairy produce, capsules, tablets, pills, and combinations thereof.
7. The composition according to claim 6 , wherein the companion animal food is a cat food.
8. The composition according to claim 6 , wherein the companion animal food is selected from the group consisting of a wet animal food and a dry animal food.
9. A method of maintaining or improving the health of a companion animal comprising orally administering a composition comprising a biologically purified strain of adherent lactic acid bacteria of the genus Lactobacilli isolated from resected and washed feline gastrointestinal tract having probiotic activity, and having the ability to survive and colonize the gastrointestinal tract of a companion animal, wherein said strain is selected from the group consisting of Lactobacillus salivarius ss salicinius NCIMB 41287 (AHF 122A), Lactobacillus animalis NCIMB 41288 (AHF 223C), and Lactobacillus reuteri NCIMB 41289 (AHF 5119) and a carrier.
10. The method according to claim 9 , wherein the strain has at least 33% growth when cultured in the presence of 0.5% feline bile salts.
11. The method according to claim 9 , wherein the strain is able to maintain viability following 1 hour at pH 2.5.
12. The method according to claim 9 , wherein the lactic acid bacterial strain has a 16s-23s spacer region DNA sequence having greater than 94% homology to SEQ. ID NO. 1, greater than 93% homology to SEQ. ID NO. 2, or greater than 98% homology to SEQ. ID NO. 3.
13. The method according to claim 9 , wherein the lactic acid bacterial strain has a 16s-23s spacer region DNA sequence selected from SEQ. ID NO. 1, SEQ. ID NO. 2, or SEQ. ID NO. 3.
14. The method according to claim 9 , for the regulation of or improvement of the immune system of a companion animal.
15. The method according to claim 14 , for treating autoimmune disease in a companion animal.
16. The method according to claim 14 , for treating inflammation in a companion animal.
17. The method according to claim 9 , for maintaining or improving the health of the skin and/or coat system of a companion animal.
18. The method according to claim 17 , for treating atopic disease of the skin of a companion animal.
19. The method according to claim 9 , for ameliorating or reducing the effects of aging in a companion animal.
20. The method according to claim 9 , for treating weight loss during and following infection in a companion animal.
21. The method according to claim 9 , for treating gastrointestinal infection in a companion animal.
22. The method according to claim 21 , for improving microbial ecology of a companion animal.
23. The method according to claim 22 , comprising reducing the levels of pathogenic bacteria in the faeces of a companion animal.
24. The method according to claim 23 , wherein said pathogenic bacteria are selected from the group consisting of Clostridia, Escherichia, Salmonella , and mixtures thereof.
25. The method according to claim 9 , for treating an urinary tract ailment in a companion animal.
26. The method according to claim 25 , wherein said urinary tract ailment comprises urinary tract infection.
27. The method according to claim 25 , wherein said urinary tract ailment comprises urinary tract stones.
28. The method according to claim 9 , for increasing fiber digestion in a companion animal.
29. The method according to claim 9 , for reducing stress levels in a companion animal.
30. The method according to claim 29 , wherein said stress levels are measured by determining the level of stress hormones selected from the group consisting of epinephrine, norepinephrine, dopamine, cortisol, C-reactive protein and mixtures thereof.
31. The method according to claim 9 , wherein the strain is fed to a companion animal in any amount from 1.0E+04 to 1.0E+12 CFU/animal per day.
32. The method according to claim 9 , wherein the companion animal is a cat.
33. A method of reducing odor associated with the feces or urine of a companion animal comprising orally administering a composition comprising a biologically purified strain of adherent lactic acid bacteria of the genus Lactobacilli isolated from resected and washed feline gastrointestinal tract, having probiotic activity, and having the ability to survive and colonize the gastrointestinal tract of a companion animal, wherein said strain is selected from the group consisting of Lactobacillus salivarius ss salicinius NCIMB 41287 (AHF 122A), Lactobacillus animalis NCIMB 41288 (AHF 223C), and Lactobacillus reuteri NCIMB 41289 (AHF 5119), and a carrier.
34. A method of reducing odor associated with a litter box of a companion animal comprising orally administering a composition comprising a biologically purified strain of adherent lactic acid bacteria of the genus Lactobacilli isolated from resected and washed feline gastrointestinal tract, having probiotic activity, and having the ability to survive and colonize the gastrointestinal tract of a companion animal, wherein said strain is selected from the group consisting of Lactobacillus salivarius ss salicinius NCIMB 41287 (AHF 122A), Lactobacillus animalis NCIMB 41288 (AHF 223C), and Lactobacillus reuteri NCIMB 41289 (AHF 5119), and a carrier.
35. The method according to claim 34 , wherein said composition is in a form selected from the group consisting of a companion animal food, kibbles, chews, a supplement, a gravy, yoghurt, cheese, dairy produce, capsules, tablets, pills, and combinations thereof.